IO Biotech Inc
IOBT
查看详细走势图
0.664USD
+0.042+6.83%
收盘 12/19, 16:00（美东）报价延迟15分钟
46.31M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
+6.83%
5天
-17.72%
1月
-10.06%
6月
-48.88%
今年开始到现在
-27.77%
1年
-13.81%
查看详细走势图
TradingKey IO Biotech Inc股票评分
单位: USD 更新时间: 2025-10-27操作建议
当前估值低估，机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价max_target_price。目前股价在压力位和支撑位之间，可以做区间波段操作。
IO Biotech Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
6
位分析师
买入
评级
2.463
目标均价
+227.70%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
IO Biotech Inc亮点
亮点风险
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
利润高增长
公司净利润处于行业前列，最新年度总收入0.00美元
估值高估
公司最新PE估值-0.58，处于3年历史高位
机构减仓
最新机构持股42.06M股，环比减少24.13%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓，最新持仓市值139.30K
活跃度增加
近期活跃度增加，过去20天平均换手率13.93
IO Biotech Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
IO Biotech Inc简介
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
公司代码IOBT
公司IO Biotech Inc
CEOZocca (Mai-Britt)
网址https://www.iobiotech.com/
常见问题
IO Biotech Inc(IOBT)的当前股价是多少？
IO Biotech Inc(IOBT)的当前股价是 0.664。
IO Biotech Inc的股票代码是什么？
IO Biotech Inc的股票代码是IOBT。
IO Biotech Inc股票的52周最高点是多少？
IO Biotech Inc股票的52周最高点是2.790。
IO Biotech Inc股票的52周最低点是多少？
IO Biotech Inc股票的52周最低点是0.323。
IO Biotech Inc的市值是多少？
IO Biotech Inc的市值是46.31M。
IO Biotech Inc的净利润是多少？
IO Biotech Inc的净利润为-95.49M。
现在IO Biotech Inc(IOBT)的股票是买入、持有还是卖出？
根据分析师评级，IO Biotech Inc(IOBT)的总体评级为买入，目标价格为2.463。
IO Biotech Inc(IOBT)股票的每股收益（EPS TTM）是多少
IO Biotech Inc(IOBT)股票的每股收益（EPS TTM）是-1.336。
相关品种
